Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)
China · Delayed Price · Currency is CNY 61.72
+0.83 (1.36%)
At close: Jul 22, 2025, 2:57 PM CST
SHE:301033 Revenue
Medprin Regenerative Medical Technologies had revenue of 73.70M CNY in the quarter ending March 31, 2025, with 28.84% growth. This brings the company's revenue in the last twelve months to 294.94M, up 21.08% year-over-year. In the year 2024, Medprin Regenerative Medical Technologies had annual revenue of 278.44M with 20.61% growth.
Revenue (ttm)
294.94M
Revenue Growth
+21.08%
P/S Ratio
13.85
Revenue / Employee
875.19K
Employees
337
Market Cap
4.08B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |